3/27
08:04 pm
pgen
Is Precigen (PGEN) The Hot Biotech Stock Under $5? [Yahoo! Finance]
Medium
Report
Is Precigen (PGEN) The Hot Biotech Stock Under $5? [Yahoo! Finance]
3/20
08:05 am
pgen
Precigen, Inc. (NASDAQ: PGEN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Medium
Report
Precigen, Inc. (NASDAQ: PGEN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
3/19
04:05 pm
pgen
Precigen Reports Full Year 2024 Financial Results and Business Updates
Low
Report
Precigen Reports Full Year 2024 Financial Results and Business Updates
3/13
08:05 am
pgen
Precigen to Announce Full Year 2024 Financial Results and Provide Business Updates on March 19th
Medium
Report
Precigen to Announce Full Year 2024 Financial Results and Provide Business Updates on March 19th
3/6
07:29 am
pgen
Orbital Therapeutics Appoints Geno Germano, Biopharma Veteran, to its Board of Directors [Yahoo! Finance]
Low
Report
Orbital Therapeutics Appoints Geno Germano, Biopharma Veteran, to its Board of Directors [Yahoo! Finance]
2/25
09:57 am
pgen
Maryland Tech Council Announces Finalists for 2025 ICON Awards [Yahoo! Finance]
Low
Report
Maryland Tech Council Announces Finalists for 2025 ICON Awards [Yahoo! Finance]
2/25
09:33 am
pgen
RBC cuts GDS rating after stock's strong rally [Yahoo! Finance]
High
Report
RBC cuts GDS rating after stock's strong rally [Yahoo! Finance]
2/25
08:41 am
pgen
FDA Grants Priority Review to Precigen's BLA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis with PDUFA Target Action Date Set for August 27, 2025 [Yahoo! Finance]
High
Report
FDA Grants Priority Review to Precigen's BLA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis with PDUFA Target Action Date Set for August 27, 2025 [Yahoo! Finance]
2/25
08:05 am
pgen
FDA Grants Priority Review to Precigen's BLA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis with PDUFA Target Action Date Set for August 27, 2025
Low
Report
FDA Grants Priority Review to Precigen's BLA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis with PDUFA Target Action Date Set for August 27, 2025
1/23
08:02 am
pgen
Precigen, Inc. (NASDAQ: PGEN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock, up previously from $4.00.
High
Report
Precigen, Inc. (NASDAQ: PGEN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock, up previously from $4.00.
1/14
09:54 am
pgen
Precigen, Inc. (NASDAQ: PGEN) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $5.00 price target on the stock.
Low
Report
Precigen, Inc. (NASDAQ: PGEN) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $5.00 price target on the stock.
1/14
09:46 am
pgen
Former FBI Agent and Executive Protection Specialist William A. Kurtz Joins Guidepost Solutions as Vice President of Protective Services [Yahoo! Finance]
Low
Report
Former FBI Agent and Executive Protection Specialist William A. Kurtz Joins Guidepost Solutions as Vice President of Protective Services [Yahoo! Finance]
1/13
07:00 am
pgen
Precigen to Present Plans for Realizing Commercial Vision for PRGN-2012 at the 43rd Annual J.P. Morgan Healthcare Conference
Medium
Report
Precigen to Present Plans for Realizing Commercial Vision for PRGN-2012 at the 43rd Annual J.P. Morgan Healthcare Conference
1/10
09:56 am
pgen
Precigen to Present at the 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Neutral
Report
Precigen to Present at the 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
1/9
08:30 am
pgen
Precigen to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Medium
Report
Precigen to Present at the 43rd Annual J.P. Morgan Healthcare Conference